NHS England

This page summarises the contracts and suppliers linked to this buyer in published notices. Values come from those notices.

Award history

Published records by year

Totals include values only when they can be added without obvious duplication. Framework totals and inconsistent values stay on their records but are not added here.

Annual award records and published values included in totals
Year	Awards	Value counted	Values not counted
2025	3	£1,248,178,692	0
2024	6	£905,187,093	2

Supplier relationships

Supplier relationships by value counted

Suppliers are ordered by published value assigned to one supplier, then by award count. Values shared between suppliers or marked as inconsistent are not assigned.

Public buyerNHS England

Published end dates

Contracts with end dates in the next 24 months

9 awards.

NHS Framework - Blood Disorders including Haemophilia A and B - July 2024
Supplier: BIO PRODUCTS LABORATORY LIMITED; CSL BEHRING UK LIMITED; LFB; Novo Nordisk; OCTAPHARMA LIMITED; Pfizer Ltd; Roche Products Ltd; Sobi (Swedish Orphan Biovitrum Ltd); Takeda UK Ltd
End date in notice
30 Apr 2027
Value shown in notice
£765,000,000Whole award value; not assigned to one supplier
Official source
Open the official Contracts Finder notice for NHS Framework - Blood Disorders including Haemophilia A and B - July 2024
About this figure
- This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
- This value appears on 2 awards in the same procurement, so it is not included in summary totals.
View record references
Source
Contracts Finder
Award or lot reference
ocds-b5fd17-78480ca7-506a-4fbd-ab2d-b535c8904519 / ocds-b5fd17-78480ca7-506a-4fbd-ab2d-b535c8904519-1

NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2)

Supplier: AOP Orphan Ltd; Accord-UK Ltd; Arcadia Pharma Ltd T/A Arcadia Medical; Ascend Laboratories UK Ltd; Aspen Pharmacare UK Limited; Baxter Healthcare Ltd; Bayer Plc; Beaumont Pharma Ltd; Bristol Laboratories; Brown & Burk UK Ltd; Chiesi Limited; Cipla; Clydesdale Pharma ltd; Correvio GmbH; Crescent Pharma Limited; Derma UK; Dr Falk Pharma UK Ltd; Drugsrus Ltd; ERAMOL (UK) LTD; Evolan Pharma; Ferring Pharmaceuticals Limited; Focus Pharmaceuticals Limited; Galen; Galvany Pharma; Genesis Pharmaceuticals Ltd; JCSH Pharma Ltd; Krka UK ltd; Kyowa Kirin Ltd; LOGIXX PHARMA LIMITED; Lundbeck Ltd; Lupin Healthcare (UK) Limited; MSN Laboratories Europe Limited; Macure Pharma Aps; Manx Healthcare Ltd; Medley Pharma Ltd; Necessity Supplies Limited; Neon Healthcare; Norgine Pharmaceuticals Limited; ORION PHARMA (UK) LIMITED; Oralieve UK Ltd; P M Pharma; Phoenix Lab; REIG JOFRE UK LIMITED; RPH Pharmaceuticals AB; Reckitt Benckiser; Recordati Pharmaceuticals Ltd; Relonchem Ltd; Rivopharm UK Ltd; STIRLING ANGLIAN PHARMACEUTICALS LIMITED; STRIDES PHARMA UK LTD; Scope Ophthalmics Limited; Strandhaven Ltd T/A Somex Pharma; Synchrony; Syri Limited (T/A Thame Laboratories); THEA PHARMACEUTICALS LIMITED; TILLOMED LABORATORIES LIMITED; Takeda UK Ltd; Tetris Pharma Lts; Torrent Pharma UK Ltd; Typharm; Uni Health Distribution Ltd; Vantage Pharmaceuticals Ltd; Waymade PLC

End date in notice: 31 May 2027
Value shown in notice: £1Whole award value; not assigned to one supplier
Official source: Open the official Contracts Finder notice for NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2)

About this figure

This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.

View record references

Source: Contracts Finder
Award or lot reference: ocds-b5fd17-473f438e-1571-48a1-aa1d-5a4342588eda / ocds-b5fd17-473f438e-1571-48a1-aa1d-5a4342588eda-1

NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)

Supplier: AGB Pharma; AMAROX LIMITED; Abbvie Ltd; Aguettant Ltd; Alissa Healthcare Research Limited; Aspire Pharma Ltd; Aventis Pharma ltd t/a Sanofi; B. Braun Medical Limited; Bowmed Ibisqus Ltd; CST PHARMA LIMITED; Colonis Pharma Ltd; Consilient Health Ltd; DR REDDY'S LABORATORIES (UK) LIMITED; Day Lewis Medical Ltd; Desitin Pharma Ltd; Ennogen Healthcare Ltd; Esteve Pharmaceuticals Limited; Flexipharm Austrading Ltd; Flynn Pharma Ltd; Fresenius Kabi Limited; GH Pharma Ltd; GLENMARK PHARMACEUTICALS EUROPE LIMITED; Gennisium Pharma; Gerot Lannach UK Ltd; GlaxoSmithKline UK Limited; Healthcare Pharma Ltd; Ipca Laboratories UK Ltd; Janssen-Cilag Ltd; Kent Pharma Ltd; Lucane Pharma; MERCURY PHARMACEUTICALS LIMITED; Macleods Pharma UK Limited; Martindale Pharma; Medreich PLC; Milpharm Ltd/aurobinbdo Primary; Morningside Pharmaeuticals; Mylan; NOVUMGEN LIMITED; Neuraxpharm UK Ltd; Organon Pharmaceuticals UK Ltd; Otsuka Pharmaceuticals UK Limited; PARI; Panpharma UK Limited; Perennial Pharma Ltd; Pfizer Ltd; Piramal Critical care Limited; ROSEMONT PHARMACEUTICALS LTD; ROVI Biotech Limited; Roma Pharmaceuticals Limited; Sandoz Ltd; Seacross Pharmaceuticals Ltd; Selective Supplies Limited; Sobi (Swedish Orphan Biovitrum Ltd); Sun Pharma UK Ltd; Teva UK Limited; Thornton and Ross Ltd; Tillotts Pharma UK Ltd; Torbay Pharmaceuticals; Venture Healthcare Ltd; Wockhardt UK Limited; ZENTIVA PHARMA UK LIMITED; hameln pharma ltd; medac Pharma LLP

End date in notice: 31 May 2027
Value shown in notice: £1Whole award value; not assigned to one supplier
Official source: Open the official Contracts Finder notice for NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)

About this figure

This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.

View record references

Source: Contracts Finder
Award or lot reference: ocds-b5fd17-92e06515-73f7-4927-9db0-0ae5cae7907f / ocds-b5fd17-92e06515-73f7-4927-9db0-0ae5cae7907f-1

NHS England | Bidwake

NHS England

Published records by year

Supplier relationships by value counted

Contracts with end dates in the next 24 months

NHS Framework - Blood Disorders including Haemophilia A and B - July 2024

NHS Framework - Blood Disorders including Haemophilia A and B - July 2024

NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2)

NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)

NHS National Generic Pharmaceuticals Wave 15a

NHS National Generic Pharmaceuticals - Clozapine

NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025

NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National

NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin